For a few dollars more: Behind the half-billion-dollar deal for an East Bay Parkinson’s Disease drug company

What started with an unsolicited offer last October turned into major acquisition of Adamas Pharmaceuticals by an East Coast specialty drug maker one year later.

Click to view original post